EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CHMP4A stimulates CD8 + T‐lymphocyte infiltration and inhibits breast tumor growth via the LSD1 / IFNβ axis

Songze Song, Deyu Zhang, Jingyi Chen, Lin Qi, Mengting Zhang, Xiao Yang, Tianxing Ye, Qinong Ye iD, Jing Lin

Cancer Science · 2023

DOI: 10.1111/cas.15844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Songze Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base of Jinzhou Medical University, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8+ T lymphocyte‐mediated immunity strategies have represented attractive weapons against breast cancer (BC) recently. However, the mechanisms underlying CD8+ T‐lymphocyte infiltration still remain obscure. Here, using bioinformatics analysis, we identified four hub prognostic genes related to CD8+ T‐lymphocyte infiltration (CHMP4A, CXCL9, GRHL2, and RPS29), among which CHMP4A was the most significant gene. High CHMP4A mRNA expression was significantly associated with longer overall survival (OS) in BC patients. Functional experiments showed that CHMP4A had the ability to promote CD8+ T‐lymphocyte recruitment and infiltration and suppressed BC growth in vitro and in vivo. Mechanistically, CHMP4A stimulates CD8+ T‐lymphocyte infiltration by downregulating LSD1 expression, leading to HERV dsRNA accumulation, and promoting IFNβ and its downstream chemokine production. Collectively, CHMP4A is not only a novel positive predictor for prognosis in BC but also a stimulator of CD8+ T‐lymphocyte infiltration regulated by the LSD1/IFNβ pathway. This study suggests that CHMP4A may be a novel target for improving the effectiveness of immunotherapy in patients with BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMammary Neoplasms, AnimalAnimalsHumansFemaleCD8-Positive T-LymphocytesPrognosisHistone DemethylasesEndosomal Sorting Complexes Required for Transport

Stichwörter der Autor:innen

HERV dsRNAbioinformaticschemokineimmunitytumor suppressor

Substanzen

Histone DemethylasesCHMP4A protein, humanEndosomal Sorting Complexes Required for Transport

Autor:innen und Institutionen

  • Postgraduate Training Base of Jinzhou Medical University, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
  • Department of Laboratory Medicine, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Qinong Ye

Förderung

  • the National Natural Science Foundation

Zitieren

APA

Song, S., Zhang, D., Chen, J., Qi, L., Zhang, M., Yang, X., Ye, T., Ye, Q., & Lin, J. (2023). CHMP4A stimulates CD8 + T‐lymphocyte infiltration and inhibits breast tumor growth via the LSD1 / IFNβ axis. Cancer Science. https://doi.org/10.1111/cas.15844

Vancouver

Song S, Zhang D, Chen J, Qi L, Zhang M, Yang X, et al. CHMP4A stimulates CD8 + T‐lymphocyte infiltration and inhibits breast tumor growth via the LSD1 / IFNβ axis. Cancer Science. 2023. doi:10.1111/cas.15844

BibTeX
@article{Song2023,
  author = {Song, Songze and Zhang, Deyu and Chen, Jingyi and Qi, Lin and Zhang, Mengting and Yang, Xiao and Ye, Tianxing and Ye, Qinong and Lin, Jing},
  title = {CHMP4A stimulates CD8 + T‐lymphocyte infiltration and inhibits breast tumor growth via the LSD1 / IFNβ axis},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15844}
}
Kostenlos starten →